文献速递前列腺癌

前列腺癌的质子与光子放射治疗:价值导向癌症治疗时代的新证据与考量

Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2019-04-09

本文通过广泛文献综述,讨论质子束技术在前列腺癌治疗中的历史、作用、争议、新技术趋势、成本效益及正在进行的现代大型前瞻性研究。现有数据显示质子束治疗与标准治疗一样安全有效,但尚无研究证明质子较光子有明确获益,剂量学研究仅提示全身辐射剂量更低和理论上相对生物效应更高。

要点

  • 现有数据表明质子束治疗前列腺癌与标准治疗一样安全有效。
  • 尚无研究证明质子较光子有明确获益,剂量学研究仅提示全身辐射剂量更低和理论上相对生物效应更高。
  • 质子治疗输送和质子中心商业模式的演变趋势有助于降低成本。

核心结论

  • 质子治疗输送的演变趋势和质子中心商业模式有助于降低成本。
  • 将现有技术引入质子输送可进一步控制器官运动并处理危及器官。
  • 备受期待的以患者报告生活质量为主要终点的当代光子与质子治疗对比研究,将帮助理解现代质子与光子治疗前列腺癌的差异。

研究设计与样本

  • 对全部质子治疗相关前列腺癌研究进行广泛文献综述。

主要发现

  • 现有数据表明质子束治疗与前列腺癌标准治疗选择相比安全有效。
  • 剂量学研究提示质子较光子全身辐射剂量更低、理论上相对生物效应更高,但无研究证明质子有明确获益。
  • 数据迄今限于大型观察性研究,尚未证明质子较常规调强放射治疗有明确获益。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 数据迄今限于大型观察性研究,尚未证明质子较常规调强放射治疗有明确获益。
  • 尚无研究证明质子较光子有明确获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advances in radiation technology have transformed treatment options for patients with localized prostate cancer. The evolution of three-dimensional conformal radiation therapy and intensity-modulated radiation therapy (IMRT) have allowed physicians to spare surrounding normal organs and reduce adverse effects. The introduction of proton beam technology and its physical advantage of depositing its energy in tissue at the end-of-range maximum may potentially spare critical organs such as the bladder and rectum in prostate cancer patients. Data thus far are limited to large, observational studies that have not yet demonstrated a definite benefit of protons over conventional treatment with IMRT. The cost of proton beam treatment adds to the controversy within the field. METHODS: We performed an extensive literature review for all proton treatment-related prostate cancer studies. We discuss the history of proton beam technology, as well as its role in the treatment of prostate cancer, associated controversies, novel technology trends, a discussion of cost-effectiveness, and an overview of the ongoing modern large prospective studies that aim to resolve the debate between protons and photons for prostate cancer. RESULTS: Present data have demonstrated that proton beam therapy is safe and effective compared with the standard treatment options for prostate cancer. While dosimetric studies suggest lower whole-body radiation dose and a theoretically higher relative biological effectiveness in prostate cancer compared with photons, no studies have demonstrated a clear benefit with protons. CONCLUSIONS: Evolving trends in proton treatment delivery and proton center business models are helping to reduce costs. Introduction of existing technology into proton delivery allows further control of organ motion and addressing organs-at-risk. Finally, the much-awaited contemporary studies comparing photon with proton-based treatments, with primary endpoints of patient-reported quality-of-life, will help us understand the differences between proton and photon-based treatments for prostate cancer in the modern era.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Kamran SC, Light JO, Efstathiou JA, et al. Proton versus photon-based radiation therapy for prostate cancer: emerging evidence and considerations in the era of value-based cancer care. Prostate Cancer Prostatic Dis. 2019. PMID: 30967625. doi:10.1038/s41391-019-0140-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。